Contact Supplier

Contact Supplier

To get in touch with TAmiRNA GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier


    TAmiRNA offers SARS CoV-2 RNA lab assay service as aid to Covid-19 testing

    products-servicesTAmiRNA GmbH
    April 29th 2020

    Biotech innovator TAmiRNA offers a SARS-Cov-2-PCR laboratory testing service for direct detection of SARS-CoV-2 viral RNA in biological samples. The RT-qPCR protocol implemented at TAmiRNA follows WHO guidelines for direct detection of a viral coronavirus infection and can serve as an aid in testing for Covid-19.

    The service provides rapid (<3h) screening for positive Covid-19 cases using a CE-IVD multiplex assay for SARS-CoV-2 N-gene and an internal positive control from Austrian company Ingenetix (

    CoV-2 testing service features

    TAmiRNA’s Cov-2 testing service enables rapid screening for positive cases based on detection of the SARS-CoV-2 N-gene, an internal positive control, and RNaseP, which helps to confirm proper sample collection. In subjects with a negative N-gene test result, a coronavirus infection can be ruled out. Subjects with a positive N-gene test result must undergo follow-up confirmation using a laboratory-developed assay to detect the SARS-CoV-2 specific E-gene.

    Two service options are available: research-use testing or diagnostic testing with medical diagnosis report.
    TAmiRNA also offers an immunochromatographic assay test kit that can identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgM & IgG antibodies in human whole blood, serum or plasma sample.

    Cov-2 testing applications

    The TAmiRNA SARS Cov-2 testing service is intended as a routine diagnostic service for medical doctors and hospitals. Research services are intended to support academic and clinical research groups, pharmaceutical companies and research laboratories in their Covid-19 research projects. Nose and throat swab samples are eligible to be tested for medical diagnosis, while blood, serum, plasma, urine, or stool samples can be processed for research-use applications.

    TAmiRNA provides its customers with an interactive electronic report, highlighting:

    • whether a sample was tested positively or negatively for SARS-CoV-2
    • the performance of all assay controls
    • quantitative insights into viral RNA load

    For diagnostic-use, a medical diagnosis report is provided.

    SARS Cov-2 testing service benefits

    The testing service can provide rapid (< 3h) information about infections with SARS-CoV-2 in human derived samples. High sensitivity and specificity are ensured based on the fact that all positive results will be confirmed with a second PCR test for SARS-CoV-2 E-Gene according to WHO recommendations.

    Other benefits include:

    • Flexible number of samples with no upper or lower limit restrictions
    • Each assay requires only 100 µl of liquid nose or throat swab samples
    • Quality control of all samples included
    • Excellent data quality ensured, with all samples are handled by expert scientific teams

    About TAmiRNA

    TAmiRNA specializes in technologies for profiling levels of blood-circulating microRNAs and developing multi-parametric classification algorithms (“signatures”). TAmiRNA uses these technologies to develop minimal-invasive diagnostic tests for drug development, early diagnosis and prognosis of disease, and as companion diagnostic tests to support treatment decisions.
    More information available at:


    Click on TAmiRNA CoV-2 testing service for further details.
    Click on SARS-CoV-2 Antibody Lateral Flow Test for details of test kit.


    hepatomiR® is a blood-based Biomaker for the Assessment of Live Function before Hepatectomy in patients with HCC, CCC or mCRC


    Contact TAmiRNA GmbH

    Simply fill out the form below to contact TAmiRNA GmbH now.

    Send TAmiRNA GmbH a Message